Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Preferred Stock Liabilities: 2020-2023

Historic Preferred Stock Liabilities for Mimedx Group (MDXG) over the last 3 years, with Sep 2023 value amounting to $92.5 million.

  • Mimedx Group's Preferred Stock Liabilities changed negligibly% to $92.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $92.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $92.5 million for FY2022, which is negligibly% changed negligibly from last year.
  • Per Mimedx Group's latest filing, its Preferred Stock Liabilities stood at $92.5 million for Q3 2023, which was down 0.00% from $92.5 million recorded in Q2 2023.
  • Mimedx Group's Preferred Stock Liabilities' 5-year high stood at $92.5 million during Q2 2021, with a 5-year trough of $91.1 million in Q3 2020.
  • Moreover, its 3-year median value for Preferred Stock Liabilities was $92.5 million (2023), whereas its average is $92.5 million.
  • Data for Mimedx Group's Preferred Stock Liabilities shows a peak YoY grew of 1.52% (in 2021) over the last 5 years.
  • Over the past 4 years, Mimedx Group's Preferred Stock Liabilities (Quarterly) stood at $91.6 million in 2020, then grew by 1.01% to $92.5 million in 2021, then remained steady at $92.5 million in 2022, then remained steady at $92.5 million in 2023.
  • Its last three reported values are $92.5 million in Q3 2023, $92.5 million for Q2 2023, and $92.5 million during Q1 2023.